A MESSAGE FROM SERGE WEINBERG, CHAIRMAN OF THE BOARD OF DIRECTORS
A SOLID GROUP WITH A UNIQUE PROFILE SERVING LIFE SCIENCES
Serge Weinberg, Chairman of the Board of Directors.
Sanofi has become one of the world’s leading pharmaceutical companies. Since our Group was founded, we have remained true to the vital objective of combatting disease and promoting health worldwide. Our unique profile means we can address disorders along the entire continuum of care, from prevention to treatment. We protect and treat hundreds of millions of people exposed to prevalent diseases, just as we protect hundreds of individuals suffering from rare diseases. Our therapeutic solutions include innovative and sophisticated treatments, as well as self-medication solutions.
The breadth and depth of our therapeutic-solution portfolio and our global presence is what makes Sanofi so unique. We operate on every continent, in over 100 countries, with a special focus on emerging countries, where we are ranked number one.
On November 6, Olivier Brandicourt presented the Group’s strategic roadmap: this plan includes reshaping our activities to increase market penetration, strengthening our R&D pipeline to ensure long-term growth and simplifying our organizational structure to guarantee greater efficiency and responsibility within our teams and when launching new medicines and vaccines.
The year 2015 was marked by the launch of three major drugs: Toujeo® for diabetes, Praluent® for hypercholesterolemia, and Dengvaxia®, the world’s first vaccine for dengue fever, as well as regulatory submissions to market three new innovative drugs. In addition, several new research partnerships were signed in oncology and diabetes. A dynamic movement has begun which is now gaining momentum and paving the way to solid growth prospects by virtue of a streamlined strategy. This dynamic is further driven by our unwavering commitment to promote widespread access to healthcare and more effectively protect the environment and resources, proven by our commitments.
Sanofi’s success and our tremendous contribution to health reflect the steadfast commitment of everyone involved. I praise the dedication of the 110,000 employees who work hard every day to make our Group a leading company in life sciences, for the benefit of patients across the globe.